Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)

Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)

Introduction The management of mid and low rectal cancer is based on neoadjuvant chemoradiotherapy (CRT) followed by standardised surgery. There is no biomarker in rectal cancer to aid clinicians in foreseeing treatment response. The determination of factors associated with treatment response might...

Full description

Bibliographic Details
Main Authors: Nicolas Barnich, Philippe Rouanet, Marta Jarlier, Caroline Chevarin, Johan Gagniere, Mathilde Bonnet, Pierre-Emmanuel Colombo, Guillaume Carrier, Hélène de Forges, Christophe Taoum, Gwenaelle Roche, Catherine Fiess
Format: Article
Language:English
Published: BMJ Publishing Group 2022-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/12/e061527.full

Internet

https://bmjopen.bmj.com/content/12/12/e061527.full

Similar Items